UK medtech companies are tackling some of healthcare's biggest challenges, from AI-driven diagnostics and advanced surgical robotics to innovative drug delivery platforms.

The Department of Health and Social Care's first-ever Medical Technology Strategy, launched in 2023, signals strong government backing for medtech innovation and wider NHS implementation. Investment has continued to pour into the sector since, with private companies now driving the future direction of healthcare delivery.

Defining Medtech

Medtech encompasses any technology designed to support prevention, diagnosis, monitoring, or treatment of health conditions. The spectrum covers wearable monitors, imaging equipment, surgical robots, and AI-driven drug design platforms.

Recent years have seen the term increasingly associated with high-tech, next-generation innovations improving clinical outcomes and enhancing patient experience. Contemporary medtech solutions enable earlier disease detection, more personalised treatment, and streamlined care delivery at scale.

Britain has long led global medical innovation. From MRI scanner invention to advances in sequencing and diagnostics, the country's universities, research centres, and startups have played pivotal industry roles. Ongoing government support, strategic investment, and cross-sector collaboration continue fuelling the UK's dynamic medtech ecosystem.

Top Ten UK Medtech Companies by Investment

10. F2G
Founded: 1998 | Base: Macclesfield | Capital Raised: £283m
This biopharmaceutical company develops novel antifungal therapies treating life-threatening invasive fungal infections. Spun out from the University of Manchester, F2G addresses global unmet medical needs with first-in-class agents differing from existing treatments in their mechanism of action.
September 2024 brought $100m in funding to advance Olorofim commercialisation in the US. The company has raised £283m through 11 equity rounds.

9. Quanta
Founded: 2015 | Base: Warwick | Capital Raised: £294m
Quanta Dialysis Technologies has developed a portable haemodialysis device providing patients greater treatment access, whether in clinical environments or at home. Total capital raised: £294m across six rounds.

8. Exscientia
Founded: 2012 | Base: Dundee | Capital Raised: £300m
A pioneer in AI-driven drug discovery, Exscientia uses advanced machine learning to design and prioritise small molecule drug candidates. The company was the first globally to bring an AI-designed molecule into clinical trials and continues leading the emerging pharmatech field where AI meets drug development.
To date, Exscientia has raised £300m across seven equity rounds.

7. Verdiva Bio
Founded: 2024 | Base: Guildford | Capital Raised: £335m
This next-generation biotech company develops cardiometabolic therapies, focusing on obesity treatment. Launched in 2024, Verdiva Bio quickly attracted global attention with a £335m Series A round, among the largest early-stage raises in UK medtech history.

6. Immunocore
Founded: 2015 | Base: Abingdon | Capital Raised: £410m
This clinical-stage biotech develops T cell receptor-based medicines treating cancer, infectious diseases, and autoimmune conditions. The company's lead therapy, tebentafusp, has gained international attention as a potential oncology breakthrough.

Immunocore has raised £410m across 12 funding rounds.

5. Isomorphic Labs
Founded: 2021 | Base: London | Capital Raised: £464m
A Google DeepMind spinout, Isomorphic Labs builds a drug design platform using AI to model and engineer novel pharmaceuticals. With its cutting-edge computational biology approach, the company works to radically accelerate and improve drug discovery processes.

Isomorphic Labs raised £464m in a single March 2025 funding round.

4. Autolus Therapeutics
Founded: 2015 | Base: London | Capital Raised: £639m
Autolus Therapeutics develops T-cell therapies for cancer, using advanced cell programming to target haematological malignancies and solid tumours. Spun out from University College London, the company has become a CAR-T therapy space leader.
Total capital raised: £639m through five rounds.

3. Bicycle Therapeutics
Founded: 2015 | Base: Cambridge | Capital Raised: £673m
Bicycle Therapeutics pioneers a new therapeutic class based on its proprietary bicyclic peptide (Bicycle®) platform. These ultra-small molecules offer antibody targeting power with small molecule precision and scalability, opening new avenues in oncology and radiopharmaceuticals.
The company has raised £673m through seven equity rounds.

2. Oxford Nanopore Technologies
Founded: 2015 | Base: Oxford | Capital Raised: £1.01bn
Oxford Nanopore Technologies transforms genomics with portable DNA and RNA sequencing devices. From academic labs to global public health efforts, its real-time sequencing technology is used worldwide to analyse biological samples with speed and flexibility.
The company has raised over £1bn across 19 fundraisings.

1. CMR Surgical
Founded: 2014 | Base: Cambridge | Capital Raised: £1.03bn
Topping the list is CMR Surgical, a global leader in robotic-assisted surgery best known for its flagship Versius system. Designed to support minimally invasive procedures, Versius has received regulatory approval in the US, UK, and across Europe, rapidly gaining adoption in hospitals worldwide.
The company has raised £1.03bn through nine rounds.

GS Verde Group: Strategic Advisory for Medtech Growth

For ambitious medtech businesses, navigating the path from spinout to scale through to exit requires expert legal, financial, and commercial advice across the entire lifecycle.

At GS Verde Group, our multi-discipline corporate finance, legal, tax, accountancy, and communications teams work seamlessly together to provide end-to-end advisory services under one roof, enabling fast, effective results.

We help medtech firms become high-growth businesses by:

• Securing investments
• Planning for exit and scalability
• Developing IP and protecting innovation
• Navigating commercial and regulatory complexity
• Structuring acquisitions, M&A and spinouts

Related medtech sector transaction: 3D marketing & sales platform's latest funding round raises substantial equity

Further insights: Explore leading UK medtech companies at: https://www.beauhurst.com/blog/medtech-companies/